Liver transplantation with "rescue organ offers" within the eurotransplant area: a 2-year report from the University Hospital Essen.
Liver transplantation (LTx) is the only treatment for patients with end-stage liver failure. This report focuses on 45 deceased donor liver allografts allocated through Eurotransplant as "rescue offers," which were accepted and subsequently transplanted at our center over a two-year period. These organs had been officially offered to and rejected by other transplant centers a total of 162 times prior to our acceptance. Primary nonfunction was observed in six patients. Two of them died and four were retransplanted. Overall patient survival was 84.4%. LTx with such "rescue organs" constitutes an additional transplant option and a safe mechanism to "rescue" organs within Eurotransplant.
Sotiropoulos
Georgios C
GC
Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Germany.
Paul
Andreas
A
Gerling
Till
T
Molmenti
Ernesto P
EP
Nadalin
Silvio
S
Napieralski
Bogdan P
BP
Treckmann
Jürgen
J
Lang
Hauke
H
Saner
Fuat
F
Frilling
Andrea
A
Broelsch
Christoph E
CE
Malagó
Massimo
M
D000328:Adult; D000368:Aged; D005858:Germany; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival; D016174:Hepacivirus / Q000502:physiology; D006526:Hepatitis C / Q000473:pathology / Q000601:surgery / Q000821:virology; D006801:Humans; D008103:Liver Cirrhosis / Q000473:pathology / Q000601:surgery / Q000821:virology; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology; D008875:Middle Aged; D013997:Time Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000276:immunology; D016896:Treatment Outcome